Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib
Crossref DOI link: https://doi.org/10.1007/s10549-017-4385-3
Published Online: 2017-07-24
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kwapisz, Dorota http://orcid.org/0000-0002-2088-2544
License valid from 2017-07-24